Gene · 10769
Papers1,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ATF1 and miR-27b-3p drive intervertebral disc degeneration through the PPARG/NF-κB signaling axis. | Commun Biol | 2025 | 40369110 | PubTator, text mining | PubMed |
| Sports nutrition knowledge, source of nutrition information and dietary consumption pattern of Ugandan endurance athletes: a cross-sectional study of the Sebei sub-region. | BMC Sports Sci Med Rehabil | 2025 | 40317037 | PubTator, text mining | PubMed |
Role of the USP7/FOXO3A axis in environmentally relevant doses of arsenic-induced lung carcinogenesis: Insights from bioinformatics analysis and model of human epithelial cell malignant transformation. | Ecotoxicol Environ Saf | 2025 | 40273609 | PubTator, text mining | PubMed |
| Caregivers nutrition knowledge and perspectives on the enablers and barriers to nutrition provision for male academy football players. | J Int Soc Sports Nutr | 2025 | 40259501 | PubTator, text mining | PubMed |
| Correction to "PLK2 Inhibited Oxidative Stress and Ameliorated Hepatic Ischemia-Reperfusion Injury Through Phosphorylating GSK3β". | J Gastroenterol Hepatol | 2025 | 40207418 | PubTator, text mining | PubMed |
| Decreased PLK2 promotes atrial fibrillation in diabetic mice through Nrf2/HO-1 pathway. | Acta Diabetol | 2025 | 40080197 | PubTator, text mining | PubMed |
| Epstein-Barr virus hijacks histone demethylase machinery to drive epithelial malignancy progression through KDM5B upregulation. | Signal Transduct Target Ther | 2025 | 40059116 | PubTator, text mining | PubMed |
| A potential tumor suppressor role of PLK2 in glioblastoma. | FEBS Open Bio | 2025 | 39927502 | PubTator, text mining | PubMed |
| PLK2 and the GSK3β-NRF2 Axis: A Promising Therapeutic Target for Sepsis-Induced Cardiac Injury? | Am J Hypertens | 2025 | 39891586 | PubTator, text mining | PubMed |
| Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with 'progression/hyper-progression' recurrence. | Ann Med | 2025 | 39865865 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Genome-Wide Screening in Haploid Stem Cells Reveals Synthetic Lethality Targeting MLH1 and TP53 Deficient Tumours. | Cell Prolif | 2025 | 39814695 | PubTator, text mining | PubMed |
| Polo-Like Kinase 2 Ameliorates Lipopolysaccharide-Induced Cardiac Injury by Blocking Cardiomyocyte Ferroptosis. | Am J Hypertens | 2025 | 39789306 | PubTator, text mining | PubMed |
| PLK2 disrupts autophagic flux to promote SNCA/α-synuclein pathology. | Autophagy | 2025 | 39773002 | PubTator, text mining | PubMed |
| Increased α-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson's disease. | Neuroscience | 2025 | 39742943 | PubTator, text mining | PubMed |
Rational design of potent phosphopeptide binders to endocrine Snk PBD domain by integrating machine learning optimization, molecular dynamics simulation, binding energetics rescoring, and in vitro affinity assay. | Eur Biophys J | 2025 | 39611994 | PubTator, text mining | PubMed |
| Diagnostic value of TRIM22 in diabetic kidney disease and its mechanism. | Endocrine | 2025 | 39509016 | PubTator, text mining | PubMed |
| MRPL13 is a metastatic and prognostic marker of breast cancer: A silico analysis accompanied with experimental validation. | Gene | 2025 | 39218414 | PubTator, text mining | PubMed |
| Evaluation of general and sports nutritional knowledge of recreational athletes. | Nutr Health | 2025 | 37226425 | PubTator, text mining | PubMed |
| PLK1: A Promising Therapeutic Target for Prostate Cancer Treatment. | Serican J Med | 2024 | 42376209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10769/papers?page=3